Enteric fistula
Intestinal fistula refers to the appearance of a pathological channel between the intestines, between the intestines and other organs, or outside the body, which causes intestinal contents to flow out of the intestinal cavity, leading to a series of pathophysiological changes such as infection, fluid loss, malnutrition, and organ dysfunction.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Surgery is common -
Related symptoms:
Stomach ache feces-like substance flowing out of the abdominal wound abdominal infection abdominal distension high fever -
Concurrent disease:
Related Drugs
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Hainan Wuren Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Kunming Jida Pharmaceutical Co., Ltd.
Somatostatin
Indication: Esophageal venous bleeding caused by portal hypertension in cirrhosis; upper gastrointestinal bleeding caused by peptic ulcer, stress ulcer, and erosive gastritis; prevention and treatment of acute pancreatitis and its complications; adjuvant treatment of pancreatic, biliary, and intestinal fistulas; others: acromegaly, gastrinoma, insulinoma, and VIPoma
Manufacturer:
Qingdao Guoda Biopharmaceutical Co., Ltd.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Wuhan Hualong BIO-CHEMICAL Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Nanjing CHANG AO Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: Severe acute esophageal varicose bleeding. Severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis. Adjuvant treatment of pancreatic, biliary and intestinal fistulas. Prevention and treatment of complications after pancreatic surgery. Adjuvant treatment of diabetic ketoacidosis.
Manufacturer:
Hainan Zhonghe Pharmaceutical Co., Ltd.
Somatostatin for injection
Indication: This product is mainly used for: severe acute esophageal varicose bleeding; severe acute gastric or duodenal ulcer bleeding, or complicated by acute erosive gastritis or hemorrhagic gastritis; prevention and treatment of complications after pancreatic surgery; adjuvant treatment of pancreatic, biliary and intestinal fistulas; adjuvant treatment of diabetic ketoacidosis.
Related Ingredients